SACM1L
Basic information
Region (hg38): 3:45689056-45745412
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SACM1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 25 | 0 | 0 |
Variants in SACM1L
This is a list of pathogenic ClinVar variants found in the SACM1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-45689476-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
3-45689482-A-T | not specified | Uncertain significance (Jan 22, 2024) | ||
3-45689493-A-G | not specified | Uncertain significance (Jun 02, 2024) | ||
3-45703480-T-G | not specified | Uncertain significance (Aug 14, 2024) | ||
3-45705141-A-C | not specified | Uncertain significance (May 20, 2024) | ||
3-45705176-T-C | not specified | Uncertain significance (Nov 01, 2022) | ||
3-45706791-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
3-45706840-T-C | not specified | Uncertain significance (Dec 13, 2022) | ||
3-45706849-C-G | not specified | Uncertain significance (Dec 22, 2023) | ||
3-45709537-G-A | not specified | Uncertain significance (Apr 27, 2024) | ||
3-45709543-A-C | not specified | Uncertain significance (Jun 07, 2024) | ||
3-45709543-A-T | not specified | Uncertain significance (Jan 04, 2024) | ||
3-45709598-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
3-45709607-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
3-45714053-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
3-45719509-T-C | not specified | Uncertain significance (Jun 07, 2022) | ||
3-45719518-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
3-45719596-T-C | not specified | Uncertain significance (Nov 08, 2022) | ||
3-45722015-G-C | not specified | Uncertain significance (Nov 17, 2022) | ||
3-45722027-A-G | not specified | Uncertain significance (Sep 05, 2024) | ||
3-45722049-T-G | not specified | Uncertain significance (Apr 10, 2023) | ||
3-45722050-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
3-45722903-G-A | not specified | Uncertain significance (May 08, 2024) | ||
3-45731317-C-T | not specified | Uncertain significance (Jul 30, 2024) | ||
3-45731325-C-G | not specified | Uncertain significance (Dec 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SACM1L | protein_coding | protein_coding | ENST00000389061 | 20 | 56369 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.695 | 0.305 | 125724 | 0 | 22 | 125746 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.99 | 209 | 307 | 0.680 | 0.0000153 | 3871 |
Missense in Polyphen | 38 | 85.631 | 0.44377 | 1030 | ||
Synonymous | 0.747 | 96 | 106 | 0.908 | 0.00000563 | 1042 |
Loss of Function | 4.60 | 8 | 39.0 | 0.205 | 0.00000206 | 456 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000627 | 0.0000627 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000711 | 0.0000653 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphoinositide phosphatase that hydrolyzes phosphatidylinositol 3-phosphate (PtdIns(3)P) and phosphatidylinositol 4-phosphate (PtdIns(4)P) (PubMed:24209621). Has low activity towards PtdIns(3,5)P2 (By similarity). {ECO:0000250|UniProtKB:Q9ES21, ECO:0000269|PubMed:24209621}.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Metabolism of lipids;3-phosphoinositide degradation;Metabolism;3-phosphoinositide biosynthesis;superpathway of inositol phosphate compounds;Synthesis of PIPs at the ER membrane;Synthesis of PIPs at the Golgi membrane;PI Metabolism;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.601
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.56
Haploinsufficiency Scores
- pHI
- 0.555
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.811
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sacm1l
- Phenotype
- endocrine/exocrine gland phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- phosphatidylinositol biosynthetic process;phosphatidylinositol dephosphorylation
- Cellular component
- Golgi membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;integral component of endoplasmic reticulum membrane;AMPA glutamate receptor complex
- Molecular function
- phosphatidylinositol-3-phosphatase activity;protein binding;phosphatase activity;phosphatidylinositol bisphosphate phosphatase activity;phosphatidylinositol phosphate 4-phosphatase activity;phosphatidylinositol-4-phosphate phosphatase activity